ResMed Inc (RMD)
218.57
-1.40
(-0.64%)
USD |
NYSE |
May 17, 16:00
218.62
+0.05
(+0.02%)
Pre-Market: 20:00
ResMed Accounts Payable (Quarterly): 177.44M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 177.44M |
December 31, 2023 | 202.40M |
September 30, 2023 | 177.05M |
June 30, 2023 | 150.76M |
March 31, 2023 | 161.90M |
December 31, 2022 | 196.00M |
September 30, 2022 | 181.48M |
June 30, 2022 | 159.24M |
March 31, 2022 | 149.80M |
December 31, 2021 | 163.37M |
September 30, 2021 | 173.70M |
June 30, 2021 | 138.01M |
March 31, 2021 | 117.22M |
December 31, 2020 | 122.17M |
September 30, 2020 | 117.59M |
June 30, 2020 | 135.79M |
March 31, 2020 | 116.15M |
December 31, 2019 | 114.32M |
September 30, 2019 | 109.74M |
June 30, 2019 | 115.72M |
March 31, 2019 | 124.47M |
December 31, 2018 | 110.34M |
September 30, 2018 | 98.71M |
June 30, 2018 | 92.72M |
March 31, 2018 | 88.16M |
Date | Value |
---|---|
December 31, 2017 | 78.35M |
September 30, 2017 | 85.08M |
June 30, 2017 | 92.76M |
March 31, 2017 | 82.85M |
December 31, 2016 | 94.10M |
September 30, 2016 | 80.49M |
June 30, 2016 | 92.57M |
March 31, 2016 | 77.64M |
December 31, 2015 | 67.58M |
September 30, 2015 | 77.48M |
June 30, 2015 | 81.11M |
March 31, 2015 | 70.90M |
December 31, 2014 | 80.00M |
September 30, 2014 | 76.25M |
June 30, 2014 | 85.40M |
March 31, 2014 | 55.48M |
December 31, 2013 | 56.24M |
September 30, 2013 | 57.12M |
June 30, 2013 | 60.69M |
March 31, 2013 | 49.38M |
December 31, 2012 | 52.12M |
September 30, 2012 | 52.91M |
June 30, 2012 | 55.01M |
March 31, 2012 | 54.73M |
December 31, 2011 | 45.76M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
109.74M
Minimum
Sep 2019
202.40M
Maximum
Dec 2023
148.99M
Average
150.28M
Median
Accounts Payable (Quarterly) Benchmarks
Boston Scientific Corp | 921.00M |
Align Technology Inc | 117.24M |
Stryker Corp | 1.246B |
Haemonetics Corp | 56.84M |
Teleflex Inc | 115.94M |